Clinical Trial Detail

NCT ID NCT02841540
Title A Phase 1 Study to Evaluate H3B-8800 in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors H3 Biomedicine Inc.
Indications

chronic myelomonocytic leukemia

myelodysplastic syndrome

acute myeloid leukemia

Therapies

H3B-8800

Age Groups: adult senior

No variant requirements are available.